All (n = 230) | |
---|---|
Men n (%) | 147 (64%) |
Age, years mean (SD) | 71 (7.7) |
50-69% symptomatic carotid stenosis n (%) | 54 (23%) |
70-99% symptomatic carotid stenosis n (%) | 176 (77%) |
First recorded systolic blood pressure mean (SD) | 160 (29) |
First recorded diastolic blood pressure mean (SD) | 82 (16) |
Presenting event: Stroke n (%) | 96 (42%) |
Presenting event: Retinal artery occlusion n (%) | 12 (5%) |
Presenting event: TIA n (%) | 70 (30%) |
Presenting event: Amaurosis fugax n (%) | 52 (23%) |
Anti-platelet or anti-coagulant at first health care contact n (%) | 130 (57%) |
Anti-platelet or anti-coagulant at 2 days after first health care contact n (%) | 195 (85%) |
Anti-platelet or anti-coagulant at 7 days after first health care contact n (%) | 214 (93%) |
Blood-pressure lowering medication at first health care contact n (%) | 189 (82%) |
Blood-pressure lowering medication at 2 days after first health care contact n (%) | 198 (86%) |
Blood-pressure lowering medication at 7 days after first health care contact n (%) | 205 (89%) |
Lipid lowering medication at first health care contact n (%) | 99 (43%) |
Lipid lowering medication at 2 days after first health care contact n (%) | 142 (62%) |
Lipid lowering medication at 7 days after first health care contact n (%) | 176 (77%) |
Underwent CEA or carotid angioplasty n (%) | 183 (80%) |
Delay between presenting event and first health care contact, days median (IQR) | 0 (0-2) |
Delay between presenting event and CEA or carotid angioplasty, weeks median (IQR) | 4.1 (2.4-7.1) |
CEA or carotid angioplasty within 2 days of the presenting event | 1 (0.4%) |
CEA or carotid angioplasty within 7 days of the presenting event | 10 (4%) |
CEA or carotid angioplasty within 14 days of the presenting event | 36 (16%) |
Recurrent ipsilateral ischemic stroke n (%) | 25 (11%) |